Confluence Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$984K Sell
30,055
-63,475
-68% -$2.28M 0.02% 221
2026
Q1
$3.31M Buy
93,530
+2,366
+3% +$96.3K 0.05% 130
2025
Q4
$3.7M Sell
91,164
-30,374
-25% -$1.32M 0.06% 135
2025
Q3
$5.72M Sell
121,538
-7,474
-6% -$387K 0.08% 124
2025
Q2
$6.72M Sell
129,012
-8,306
-6% -$456K 0.09% 122
2025
Q1
$8.29M Sell
137,318
-2,887
-2% -$186K 0.12% 113
2024
Q4
$9.6M Sell
140,205
-6,737
-5% -$469K 0.13% 110
2024
Q3
$10.6M Buy
146,942
+96,081
+189% +$6.78M 0.14% 108
2024
Q2
$3.53M Buy
+50,861
New +$3.71M 0.05% 151

Other funds holding CNMD

Confluence Investment Management's CNMD Position: Q2 2026 in Review

Confluence Investment Management reduced its CONMED (CNMD) stake by 68% in Q2 2026, selling an estimated $2.28M and leaving 30,055 shares worth $984K. The position accounts for 0.02% of the portfolio, ranked #221.

Confluence Investment Management first reported a position in CNMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $10.6M in Q3 2024. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Confluence Investment Management held 30,055 shares of CONMED worth $984K as of Q2 2026.
  • Confluence Investment Management sold 63,475 CONMED shares in Q2 2026, an estimated $2.28M.
  • CONMED made up 0.02% of Confluence Investment Management's portfolio in Q2 2026, its #221 holding.
  • Confluence Investment Management first reported a position in CONMED in Q2 2024 and has held it in 9 quarters since.
  • Confluence Investment Management's CONMED position peaked at $10.6M in Q3 2024.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Confluence Investment Management's 13F filing for Q2 2026, filed 1 Jul 2026.